Se-methylselenocysteine Inhibits Migration and Glycolysis in Anaplastic Thyroid Carcinoma Cells via the ERK1/2 Signaling Pathway <i>in vitro</i>.
These findings indicated that MSC inhibited the viability, migration, and glycolysis of ATC cells via the ERK1/2 signaling pathway, suggesting that MSC may represent a novel therapeutic agent for ATC.
Authors
- Bixiu Ban
- Yuping Liu (ORCID: https://orcid.org/0000-0001-6374-7708)
- Zuojie Luo (ORCID: https://orcid.org/0000-0003-2969-8329)
- Haiyan Yang (ORCID: https://orcid.org/0000-0002-3036-3000)
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-11-01
- Primary Topic
- Selenium in Biological Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00